{"id":537934,"date":"2021-09-14T08:33:38","date_gmt":"2021-09-14T12:33:38","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/"},"modified":"2021-09-14T08:33:38","modified_gmt":"2021-09-14T12:33:38","slug":"sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/","title":{"rendered":"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress"},"content":{"rendered":"
\n

CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the World Muscle Society 2021 Virtual Congress (WMS 2021), taking place Sept. 20-24, 2021. This year\u2019s presentations at WMS 2021 highlight scientific leadership and innovation from across Sarepta\u2019s deep, multi-platform portfolio and reflect the Company\u2019s continued commitment advancing life-changing therapies to those with rare genetic diseases.<\/p>\n

Presented research will include data from the Company\u2019s gene therapy and RNA platforms, in addition to new research into the prevalence of pre-existing antibodies to the AAVrh74 vector, which is used in several of Sarepta\u2019s gene transfer therapy programs.\u00a0\u00a0 All posters are available on-demand throughout the Congress beginning on Monday, Sept. 20, 2021 at 7:00 am E.T. The full WMS 2021 program is available at https:\/\/www.wms2021.com\/page\/programme<\/a>.<\/p>\n

\n
\n Poster Presentations <\/em>
\n <\/strong>\n <\/p>\n\n\n\n\n\n\n\n\n\n\n\n
\n Poster #\u200b<\/strong>\n <\/td>\n\n Title\u200b<\/strong>\n <\/td>\n<\/tr>\n
EP.096\u200b<\/td>\nMicro-dystrophin gene therapy delivery and therapeutic plasma exchange in nonhuman primates\u200b<\/td>\n<\/tr>\n
EP.139\u200b<\/td>\nPhase 1\/2a trial of SRP-9001 in patients with Duchenne muscular dystrophy: 3-year safety and functional\u00a0outcomes (SRP-9001-101)\u200b<\/td>\n<\/tr>\n
EP.149\u200b<\/td>\nDelay in Duchenne muscular dystrophy progression with eteplirsen: Longer time to loss of ambulation\u00a0versus standard of care<\/td>\n<\/tr>\n
EP.150\u200b<\/td>\nCasimersen\u00a0in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: Interim results\u00a0from the Phase 3 ESSENCE trial\u00a0\u200b<\/td>\n<\/tr>\n
EP.151\u200b<\/td>\nEvaluation of total binding antibodies against rAAVrh74 in patients with Duchenne muscular dystrophy\u00a0\u200b<\/td>\n<\/tr>\n
EP.152\u200b<\/td>\nENDEAVOR: A gene delivery study to evaluate the safety of and expression from SRP-9001 in Duchenne\u00a0muscular dystrophy (SRP-9001-103)\u200b<\/td>\n<\/tr>\n
EP.185\u00a0\u200b<\/td>\nSafety,\u00a0\u03b2-sarcoglycan\u00a0expression, and functional outcomes from systemic gene transfer of rAAVrh74.MHCK7.SGCB in limb\u00a0girdle muscular dystrophy type 2E\/R4\u200b<\/td>\n<\/tr>\n
EP.254<\/td>\nA Phase 2 clinical trial evaluating the safety and efficacy of SRP-9001 for treating patients with Duchenne\u00a0muscular dystrophy (SRP-9001-102) \u200b<\/td>\n<\/tr>\n
LBP.22<\/td>\nSafety, tolerability, and pharmacokinetics of eteplirsen in patients 6-48 months old with Duchenne muscular dystrophy amenable to exon 51 skipping<\/td>\n<\/tr>\n<\/table>\n

Presentations will be archived on the events and presentations page in the Investor Relations section of www.sarepta.com<\/a> for one year following their presentation at WMS 2021.<\/p>\n

\n
\n About Sarepta Therapeutics<\/em>
\n <\/strong>
\n
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit\u00a0www.sarepta.com<\/a> or follow us on Twitter<\/a>, LinkedIn<\/a>, Instagram<\/a> and Facebook<\/a>.<\/p>\n

\n
\n Internet Posting of Information<\/em>
\n <\/strong>
\n
\n We routinely post information that may be important to investors in the ‘For Investors’ section of our website at\u00a0<\/em>
\n
\n
\n www.sarepta.com<\/u>
\n <\/em>
\n <\/a>
\n . We encourage investors and potential investors to consult our website regularly for important information about us.<\/em>\n <\/p>\n

Source: Sarepta Therapeutics, Inc.<\/p>\n

\n
\n Investor Contact: <\/em>
\n <\/strong>
\n
Ian Estepan, 617-274-4052
iestepan@sarepta.com<\/a><\/p>\n

\n
\n Media Contact: <\/em>
\n <\/strong>
\n
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com<\/a><\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the World Muscle Society 2021 Virtual Congress (WMS 2021), taking place Sept. 20-24, 2021. This year\u2019s presentations at WMS 2021 highlight scientific leadership and innovation from across Sarepta\u2019s deep, multi-platform portfolio and reflect the Company\u2019s continued commitment advancing life-changing therapies to those with rare genetic diseases. Presented research will include data from the Company\u2019s gene therapy and RNA platforms, in addition to new research into the prevalence of pre-existing antibodies to the AAVrh74 vector, which is used in several of Sarepta\u2019s gene transfer therapy programs.\u00a0\u00a0 All posters are available on-demand throughout the Congress beginning on Monday, … <\/p>\n

Continue reading “Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-537934","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the World Muscle Society 2021 Virtual Congress (WMS 2021), taking place Sept. 20-24, 2021. This year\u2019s presentations at WMS 2021 highlight scientific leadership and innovation from across Sarepta\u2019s deep, multi-platform portfolio and reflect the Company\u2019s continued commitment advancing life-changing therapies to those with rare genetic diseases. Presented research will include data from the Company\u2019s gene therapy and RNA platforms, in addition to new research into the prevalence of pre-existing antibodies to the AAVrh74 vector, which is used in several of Sarepta\u2019s gene transfer therapy programs.\u00a0\u00a0 All posters are available on-demand throughout the Congress beginning on Monday, … Continue reading "Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-14T12:33:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress\",\"datePublished\":\"2021-09-14T12:33:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/\"},\"wordCount\":504,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/\",\"name\":\"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=\",\"datePublished\":\"2021-09-14T12:33:38+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/","og_locale":"en_US","og_type":"article","og_title":"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress - Market Newsdesk","og_description":"CAMBRIDGE, Mass., Sept. 14, 2021 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will present at the World Muscle Society 2021 Virtual Congress (WMS 2021), taking place Sept. 20-24, 2021. This year\u2019s presentations at WMS 2021 highlight scientific leadership and innovation from across Sarepta\u2019s deep, multi-platform portfolio and reflect the Company\u2019s continued commitment advancing life-changing therapies to those with rare genetic diseases. Presented research will include data from the Company\u2019s gene therapy and RNA platforms, in addition to new research into the prevalence of pre-existing antibodies to the AAVrh74 vector, which is used in several of Sarepta\u2019s gene transfer therapy programs.\u00a0\u00a0 All posters are available on-demand throughout the Congress beginning on Monday, … Continue reading \"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-14T12:33:38+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress","datePublished":"2021-09-14T12:33:38+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/"},"wordCount":504,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/","name":"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=","datePublished":"2021-09-14T12:33:38+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyNTU5OSM0NDAzNjc3IzIwMDcxNTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sarepta-therapeutics-to-showcase-data-from-its-gene-therapy-and-rna-platforms-at-world-muscle-society-2021-virtual-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Sarepta Therapeutics to Showcase Data from its Gene Therapy and RNA Platforms at World Muscle Society 2021 Virtual Congress"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/537934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=537934"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/537934\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=537934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=537934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=537934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}